TJAP1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.51949999974244E-07 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.461390E-03 |
Normal-vs-Stage2 |
1.986420E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.570170E-04 |
Stage1-vs-Stage2 |
6.189600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.310200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
2.574200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.53489999999978E-05 |
Normal-vs-AfricanAmerican |
7.332400E-02 |
Normal-vs-Asian |
1.445990E-02 |
Caucasian-vs-AfricanAmerican |
8.022400E-01 |
Caucasian-vs-Asian |
8.366800E-01 |
AfricanAmerican-vs-Asian |
1.545760E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.68389999949592E-07 |
Normal-vs-Female |
6.027200E-04 |
Male-vs-Female |
2.660800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.583610E-04 |
Normal-vs-Extreme_Weight |
1.1188999999856E-06 |
Normal-vs-Obese |
1.4498000000529E-06 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.093800E-01 |
Normal_Weight-vs-Obese |
6.667600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.902000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.44280000356079E-08 |
Normal-vs-Age(41-60Yrs) |
3.26350000001696E-06 |
Normal-vs-Age(61-80Yrs) |
5.645500E-04 |
Normal-vs-Age(81-100Yrs) |
3.609000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.034200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.173600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.423000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.025000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.053400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.093400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.596200E-01 |
Normal-vs-Grade 3 |
4.673800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.775000E-01 |
Grade 2-vs-Grade 4 |
2.596200E-01 |
Grade 3-vs-Grade 4 |
4.673800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.32200000000105E-05 |
Normal-vs-N1 |
1.737420E-03 |
N0-vs-N1 |
1.839760E-01 |
|
|